Skip to main content
Clinical Trials/JPRN-jRCT1042220094
JPRN-jRCT1042220094
Recruiting
未知

Study of Efficacy of Spinal Cord Stimulation Compared Conventional and New Stimulation Methods for Intractable Neuropathic Pain

Saito Ryuta0 sites92 target enrollmentNovember 21, 2022
Conditionseuropathic pain

Overview

Phase
未知
Intervention
Not specified
Conditions
europathic pain
Sponsor
Saito Ryuta
Enrollment
92
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Saito Ryuta

Eligibility Criteria

Inclusion Criteria

  • Patients with intractable neuropathic pain resistance to medication treatments using more than two drugs
  • \-18 years of age or older
  • \-Pain scale of VAS (Visual analog scale) is more than 4 point
  • \-Patients who have obtained written consent from the patient

Exclusion Criteria

  • \-Patients receiving anti\-cancer therapy
  • \-Patients with a history of drug abuse
  • \-Patients with histories of spine or spinal cord surgery at the site through which the spinal cord stimulation electrode passes or will be placed
  • \-Patients for whom local and general anesthesia cannot be performed
  • \-Patients with high risk of surgery, such as patients with unstable angina pectoris and with end\-stage liver disease presenting with hepatic encephalopathy
  • \-Patients with diabetes mellitus who are not well controlled (HbA1c 9% or more)
  • \-Patients with serious complications (liver disease, kidney disease, heart disease, lung disease, blood disease, brain disease, etc.)
  • \-Pregnant or potentially pregnant patients
  • \-Patients who are considered as inappropriate by a head of research or research assignations

Outcomes

Primary Outcomes

Not specified

Similar Trials